Mantente al tanto de las últimas noticias de biotecnología con reportes de periodistas en los principales centros del mundo. Sintoniza para más información y avances.
Stevenage, UK based TessellateBio recently signed a collaboration and licensing deal with Boehringer Ingelheim targeting tumors dependent on alternative lengthening of telomeres (ALT) for their growth
10 mins • May 20, 2025
Charts
- 71Increased by 21
- 74Decreased by 7
- 114Increased by 0
- 120Decreased by 31
- 187Decreased by 9
Episodios recientes

May 20, 2025
Stevenage, UK based TessellateBio recently signed a collaboration and licensing deal with Boehringer Ingelheim targeting tumors dependent on alternative lengthening of telomeres (ALT) for their growth
10 mins

May 16, 2025
Cambridge, UK based Maxion Therapeutics raised a $72M series A in March to advance its KnotBody programs - which combine the benefits of knottins and antibodies and can target ion channels and GPCRs
14 mins

May 16, 2025
ASGCT 2025: HuidaGene presented preclinical and early clinical data for its CRISPR Cas12 based program for DMD in a Presidential Symposium talk
9 mins

May 15, 2025
ASGCT 2025: Dyno Therapeutics CEO Eric Kelsic discusses the latest in capsids for CNS, ophthalmology, and neuromuscular conditions
11 mins

May 15, 2025
ASGCT 2025: Physicians and scientists raced to make a bespoke gene editing therapy for an infant who urgently needed one in months - a first hand account, and what this means for drug development
17 mins

Idioma
Inglés
País
Estados Unidos
Feed Host
Sitio web
Feed
Solicitar una actualización
Las actualizaciones pueden tardar unos minutos.